121-135 of 937
Improving Lipid Management Through Equity-Focused Clinical Strategies
Heart MattersImproving Lipid Management Through Equity-Focused Clinical Strategies
Optimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care
Heart MattersOptimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care
PCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
Heart MattersPCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
Heart MattersIntegrating Lipoprotein(a) Into Cardiovascular Risk Assessment
Triglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Heart MattersTriglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Retinal Vein Occlusion as a Predictor of Stroke
Eye on Ocular HealthRetinal Vein Occlusion as a Predictor of Stroke
- advertisement
Navigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
GI InsightsNavigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
Thomas DeLoughery, MD
Peter Buch, MD, FACG, AGAF, FACP
Efficacy of Obicetrapib Across Diverse Background Lipid-Lowering Regimens: Pooled BROADWAY & BROOKLYN Analyses
CardiologyEfficacy of Obicetrapib Across Diverse Background Lipid-Lowering Regimens: Pooled BROADWAY & BROOKLYN Analyses
Kausik Ray, MBChB, MD, MPhil
CETP Inhibition and Obicetrapib: A New Era in Lipid Management
CardiologyCETP Inhibition and Obicetrapib: A New Era in Lipid Management
Kausik Ray, MBChB, MD, MPhil
CETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
CardiologyCETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Managing Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
GI InsightsManaging Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
Peter Buch, MD, FACG, AGAF, FACP
Neena Abraham, MD, MS
Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
CardiologyRedefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
Javed Butler, MD
- advertisement
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Heart MattersTimely ATTR-CM Diagnosis: Addressing Social Determinants of Health
Kevin Alexander, MD
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Heart MattersEquitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
Kevin Alexander, MD
Translating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
Heart MattersTranslating Patisiran’s 6-Minute Walk Test Gains into Real-Life Impact in ATTR-CM
